/

Humulin 70/30 100iu 3ml 5’s

KSh 6,200.00

Humulin 70/30 is a type of insulin that combines 70% intermediate-acting insulin (Insulin Isophane/NPH) and 30% short-acting insulin (Human Insulin/Soluble Insulin). It is used to help control blood sugar in adults and children who have type 1 or type 2 diabetes. Active Substances: Insulin Isophane Suspension (NPH): 70% and Insulin Regular: 30%

Insulin

Suggested Use

Humulin 70/30 is primarily indicated for:

  1. Improving glycemic control in adults diagnosed with diabetes mellitus.
  2. It works by stimulating peripheral glucose uptake in skeletal muscle and fat, while inhibiting hepatic glucose production, thereby lowering blood glucose levels

Dosage:

The recommended administration guidelines include:

  • Route: Only for subcutaneous use (in the abdominal wall, thigh, upper arm, or buttocks).
  • Timing: Administer approximately 30-45 minutes before meals.
  • Dosage Adjustment: Individualize based on metabolic needs and blood glucose monitoring results. Adjustments may be necessary due to physical activity changes, meal patterns, or other medications.

Warning

  1. Hypoglycemia: The most common side effect; patients should monitor blood sugar regularly and be aware of symptoms (e.g., dizziness, sweating, confusion).
  2. Allergic Reactions: Rare but serious reactions may include rash, swelling, or difficulty breathing.
  3. Medication Errors: Ensure the correct insulin product is used to prevent overdose or underdose.
  4. Insulin Pen Use: Use the pen only as instructed. Do not share insulin pens between patients to avoid cross-contamination.
  5. Storage: Store unused pens in the refrigerator (2 °C–8 °C). Do not freeze. Once in use, pens may be kept at room temperature and should be used within 28 days.
  6. Pregnancy and Lactation: Use with caution; consult a healthcare provider to adjust the dose as needed during pregnancy.
  7. Drug Interactions: Inform the doctor of all medications being taken, as certain drugs (e.g., beta-blockers, corticosteroids) may affect insulin efficacy.

Notes:
  • Always follow the healthcare provider’s instructions on insulin usage.
  • Ensure proper technique for injection to minimize complications.
  • Carry quick sources of sugar (e.g., glucose tablets, candies) to manage hypoglycemia if it occurs.
Select the fields to be shown. Others will be hidden. Drag and drop to rearrange the order.
  • Image
  • SKU
  • Rating
  • Price
  • Stock
  • Availability
  • Add to cart
  • Description
  • Content
  • Weight
  • Dimensions
  • Additional information
Click outside to hide the comparison bar
Compare

Disclaimer

The content on this website was written and edited by Dawa Poa. Our health information, as at the time of publishing, is up-to-date, evidence-based and reviewed by health professionals. Yet, it isn’t intended to replace the medical information given to you by your doctor. You should not use the information on this website for diagnosing or treating a health problem or disease, or prescribing any medication or other treatment.

We’ve provided this content for informational purposes only. Dawa Poa does not represent or warrant that the nutrition, ingredient, allergen and other product information on our Website are accurate or complete since this information comes from the product manufacturers. On occasion, manufacturers improve or change their product formulas and update their labels.

We thus recommend that you do not rely solely on the information presented on our Website. Instead, you should review the product’s label or contact the manufacturer directly if you have specific product concerns or questions. If you have specific healthcare concerns or questions about the products displayed, please contact your licensed healthcare professional for advice or answers.
We aim to provide you with the knowledge and support you need to make confident decisions about your health and well-being.

Our registered address is Ansell Pharmaceuticals Limited, Kinoo 87, off Waiyaki Way, Kiambu. Dr. David K. Karanja, a registered member, of the Pharmaceutical Society of Kenya, is the Superintendent Pharmacist for this pharmacy. Dawa Poa is our online store

Disclaimer

The content on this website was written and edited by Dawa Poa. Our health information, as at the time of publishing, is up-to-date, evidence-based and reviewed by health professionals. Yet, it isn’t intended to replace the medical information given to you by your doctor. You should not use the information on this website for diagnosing or treating a health problem or disease, or prescribing any medication or other treatment.

We’ve provided this content for informational purposes only. Dawa Poa does not represent or warrant that the nutrition, ingredient, allergen and other product information on our Website are accurate or complete since this information comes from the product manufacturers. On occasion, manufacturers improve or change their product formulas and update their labels.

We thus recommend that you do not rely solely on the information presented on our Website. Instead, you should review the product’s label or contact the manufacturer directly if you have specific product concerns or questions. If you have specific healthcare concerns or questions about the products displayed, please contact your licensed healthcare professional for advice or answers.
We aim to provide you with the knowledge and support you need to make confident decisions about your health and well-being.

Our registered address is Ansell Pharmaceuticals Limited, Kinoo 87, off Waiyaki Way, Kiambu. Dr. David K. Karanja, a registered member of the Pharmaceutical Society of Kenya, is the Superintendent Pharmacist for this pharmacy. Dawa Poa is our online store

×

Hello!

Click one of our contacts below to chat on WhatsApp

×